nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—AGTR1—dilated cardiomyopathy	0.679	1	CbGaD
Candesartan—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0872	0.409	CbGbCtD
Candesartan—ABCB1—Lisinopril—dilated cardiomyopathy	0.067	0.314	CbGbCtD
Candesartan—ABCB1—Spironolactone—dilated cardiomyopathy	0.059	0.277	CbGbCtD
Candesartan—CYP2C9—cardial valve—dilated cardiomyopathy	0.00906	0.555	CbGeAlD
Candesartan—AGTR1—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00304	0.153	CbGpPWpGaD
Candesartan—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00238	0.0383	CcSEcCtD
Candesartan—AGTR1—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00236	0.119	CbGpPWpGaD
Candesartan—Tasosartan—AGTR2—dilated cardiomyopathy	0.00219	0.245	CrCbGaD
Candesartan—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00201	0.0324	CcSEcCtD
Candesartan—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00161	0.0259	CcSEcCtD
Candesartan—AGTR1—cardiac ventricle—dilated cardiomyopathy	0.00158	0.0969	CbGeAlD
Candesartan—AGTR1—myocardium—dilated cardiomyopathy	0.00149	0.0912	CbGeAlD
Candesartan—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00142	0.0229	CcSEcCtD
Candesartan—Azilsartan medoxomil—AGTR1—dilated cardiomyopathy	0.00135	0.151	CrCbGaD
Candesartan—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00134	0.0216	CcSEcCtD
Candesartan—Renal failure—Spironolactone—dilated cardiomyopathy	0.00133	0.0214	CcSEcCtD
Candesartan—AGTR1—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00128	0.0641	CbGpPWpGaD
Candesartan—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00127	0.0204	CcSEcCtD
Candesartan—Forasartan—AGTR1—dilated cardiomyopathy	0.00125	0.14	CrCbGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.00109	0.0547	CbGpPWpGaD
Candesartan—AGTR1—heart—dilated cardiomyopathy	0.00104	0.0636	CbGeAlD
Candesartan—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000973	0.0156	CcSEcCtD
Candesartan—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000962	0.0155	CcSEcCtD
Candesartan—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000949	0.0153	CcSEcCtD
Candesartan—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000935	0.015	CcSEcCtD
Candesartan—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000897	0.0144	CcSEcCtD
Candesartan—AGTR1—cardiac atrium—dilated cardiomyopathy	0.000889	0.0544	CbGeAlD
Candesartan—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000847	0.0136	CcSEcCtD
Candesartan—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000811	0.013	CcSEcCtD
Candesartan—Somnolence—Spironolactone—dilated cardiomyopathy	0.000769	0.0124	CcSEcCtD
Candesartan—Tasosartan—AGTR1—dilated cardiomyopathy	0.000758	0.085	CrCbGaD
Candesartan—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000755	0.0121	CcSEcCtD
Candesartan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000747	0.012	CcSEcCtD
Candesartan—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000747	0.012	CcSEcCtD
Candesartan—Renal failure—Furosemide—dilated cardiomyopathy	0.000726	0.0117	CcSEcCtD
Candesartan—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000722	0.0116	CcSEcCtD
Candesartan—AGTR1—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000691	0.0347	CbGpPWpGaD
Candesartan—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000689	0.0111	CcSEcCtD
Candesartan—Urticaria—Spironolactone—dilated cardiomyopathy	0.000688	0.0111	CcSEcCtD
Candesartan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000684	0.011	CcSEcCtD
Candesartan—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000673	0.0108	CcSEcCtD
Candesartan—Valsartan—AGTR1—dilated cardiomyopathy	0.000657	0.0737	CrCbGaD
Candesartan—PTGS1—myocardium—dilated cardiomyopathy	0.000655	0.0401	CbGeAlD
Candesartan—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000654	0.0105	CcSEcCtD
Candesartan—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00065	0.0104	CcSEcCtD
Candesartan—Olmesartan—AGTR1—dilated cardiomyopathy	0.000641	0.0719	CrCbGaD
Candesartan—Telmisartan—AGTR1—dilated cardiomyopathy	0.000618	0.0693	CrCbGaD
Candesartan—Pruritus—Spironolactone—dilated cardiomyopathy	0.000612	0.00984	CcSEcCtD
Candesartan—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000605	0.00973	CcSEcCtD
Candesartan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000605	0.00973	CcSEcCtD
Candesartan—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000597	0.0096	CcSEcCtD
Candesartan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000592	0.00952	CcSEcCtD
Candesartan—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000581	0.00934	CcSEcCtD
Candesartan—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000577	0.00928	CcSEcCtD
Candesartan—Malnutrition—Furosemide—dilated cardiomyopathy	0.000577	0.00927	CcSEcCtD
Candesartan—Dizziness—Spironolactone—dilated cardiomyopathy	0.000572	0.0092	CcSEcCtD
Candesartan—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00056	0.00901	CcSEcCtD
Candesartan—Vomiting—Spironolactone—dilated cardiomyopathy	0.00055	0.00884	CcSEcCtD
Candesartan—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000546	0.00878	CcSEcCtD
Candesartan—Rash—Spironolactone—dilated cardiomyopathy	0.000546	0.00877	CcSEcCtD
Candesartan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000545	0.00876	CcSEcCtD
Candesartan—Renal failure—Lisinopril—dilated cardiomyopathy	0.000544	0.00875	CcSEcCtD
Candesartan—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000543	0.00873	CcSEcCtD
Candesartan—Headache—Spironolactone—dilated cardiomyopathy	0.000542	0.00871	CcSEcCtD
Candesartan—Anaemia—Furosemide—dilated cardiomyopathy	0.000533	0.00857	CcSEcCtD
Candesartan—Haematuria—Lisinopril—dilated cardiomyopathy	0.000528	0.00849	CcSEcCtD
Candesartan—AGTR1—Arf6 signaling events—ADRB2—dilated cardiomyopathy	0.000523	0.0263	CbGpPWpGaD
Candesartan—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000522	0.0084	CcSEcCtD
Candesartan—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00052	0.00835	CcSEcCtD
Candesartan—Vertigo—Furosemide—dilated cardiomyopathy	0.000518	0.00833	CcSEcCtD
Candesartan—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000517	0.00831	CcSEcCtD
Candesartan—Leukopenia—Furosemide—dilated cardiomyopathy	0.000516	0.0083	CcSEcCtD
Candesartan—Nausea—Spironolactone—dilated cardiomyopathy	0.000514	0.00826	CcSEcCtD
Candesartan—CYP2C9—heart—dilated cardiomyopathy	0.000501	0.0306	CbGeAlD
Candesartan—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000499	0.00801	CcSEcCtD
Candesartan—Irbesartan—AGTR1—dilated cardiomyopathy	0.000498	0.0559	CrCbGaD
Candesartan—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000497	0.00799	CcSEcCtD
Candesartan—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000494	0.00793	CcSEcCtD
Candesartan—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000491	0.00789	CcSEcCtD
Candesartan—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00049	0.00787	CcSEcCtD
Candesartan—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000487	0.00784	CcSEcCtD
Candesartan—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000461	0.00741	CcSEcCtD
Candesartan—PTGS1—heart—dilated cardiomyopathy	0.000457	0.028	CbGeAlD
Candesartan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000455	0.00732	CcSEcCtD
Candesartan—Pranlukast—TNF—dilated cardiomyopathy	0.000451	0.0506	CrCbGaD
Candesartan—Hypotension—Furosemide—dilated cardiomyopathy	0.00044	0.00707	CcSEcCtD
Candesartan—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000436	0.007	CcSEcCtD
Candesartan—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000433	0.00696	CcSEcCtD
Candesartan—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000423	0.0068	CcSEcCtD
Candesartan—Back pain—Lisinopril—dilated cardiomyopathy	0.000419	0.00673	CcSEcCtD
Candesartan—Somnolence—Furosemide—dilated cardiomyopathy	0.000419	0.00673	CcSEcCtD
Candesartan—AGTR1—Arf6 trafficking events—ADRB2—dilated cardiomyopathy	0.000413	0.0207	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000406	0.00653	CcSEcCtD
Candesartan—Fatigue—Furosemide—dilated cardiomyopathy	0.000406	0.00653	CcSEcCtD
Candesartan—Anaemia—Lisinopril—dilated cardiomyopathy	0.0004	0.00643	CcSEcCtD
Candesartan—AGTR1—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000399	0.02	CbGpPWpGaD
Candesartan—Angioedema—Lisinopril—dilated cardiomyopathy	0.000396	0.00636	CcSEcCtD
Candesartan—AGTR1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000394	0.0198	CbGpPWpGaD
Candesartan—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000391	0.0239	CbGeAlD
Candesartan—Vertigo—Lisinopril—dilated cardiomyopathy	0.000389	0.00625	CcSEcCtD
Candesartan—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000387	0.00623	CcSEcCtD
Candesartan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000385	0.00619	CcSEcCtD
Candesartan—Palpitations—Lisinopril—dilated cardiomyopathy	0.000383	0.00615	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ITGB1—dilated cardiomyopathy	0.000379	0.0191	CbGpPWpGaD
Candesartan—Cough—Lisinopril—dilated cardiomyopathy	0.000378	0.00607	CcSEcCtD
Candesartan—Urticaria—Furosemide—dilated cardiomyopathy	0.000374	0.00601	CcSEcCtD
Candesartan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000372	0.00598	CcSEcCtD
Candesartan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000372	0.00598	CcSEcCtD
Candesartan—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000369	0.00592	CcSEcCtD
Candesartan—Chest pain—Lisinopril—dilated cardiomyopathy	0.000369	0.00592	CcSEcCtD
Candesartan—Myalgia—Lisinopril—dilated cardiomyopathy	0.000369	0.00592	CcSEcCtD
Candesartan—Anxiety—Lisinopril—dilated cardiomyopathy	0.000367	0.0059	CcSEcCtD
Candesartan—AGTR1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000366	0.0184	CbGpPWpGaD
Candesartan—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000354	0.0178	CbGpPWpGaD
Candesartan—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000346	0.00556	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000345	0.0173	CbGpPWpGaD
Candesartan—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000345	0.00554	CcSEcCtD
Candesartan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000342	0.00549	CcSEcCtD
Candesartan—Asthenia—Furosemide—dilated cardiomyopathy	0.000338	0.00543	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—dilated cardiomyopathy	0.000338	0.017	CbGpPWpGaD
Candesartan—Pruritus—Furosemide—dilated cardiomyopathy	0.000333	0.00535	CcSEcCtD
Candesartan—Hypotension—Lisinopril—dilated cardiomyopathy	0.00033	0.00531	CcSEcCtD
Candesartan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000322	0.00518	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000322	0.00517	CcSEcCtD
Candesartan—Losartan—AGTR1—dilated cardiomyopathy	0.000321	0.036	CrCbGaD
Candesartan—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000317	0.0051	CcSEcCtD
Candesartan—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000315	0.00506	CcSEcCtD
Candesartan—Somnolence—Lisinopril—dilated cardiomyopathy	0.000314	0.00505	CcSEcCtD
Candesartan—Dizziness—Furosemide—dilated cardiomyopathy	0.000311	0.005	CcSEcCtD
Candesartan—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000311	0.005	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RAC1—dilated cardiomyopathy	0.000305	0.0153	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000305	0.0049	CcSEcCtD
Candesartan—Fatigue—Lisinopril—dilated cardiomyopathy	0.000305	0.0049	CcSEcCtD
Candesartan—Vomiting—Furosemide—dilated cardiomyopathy	0.000299	0.00481	CcSEcCtD
Candesartan—Rash—Furosemide—dilated cardiomyopathy	0.000297	0.00477	CcSEcCtD
Candesartan—Dermatitis—Furosemide—dilated cardiomyopathy	0.000297	0.00477	CcSEcCtD
Candesartan—Headache—Furosemide—dilated cardiomyopathy	0.000295	0.00474	CcSEcCtD
Candesartan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000289	0.00464	CcSEcCtD
Candesartan—Urticaria—Lisinopril—dilated cardiomyopathy	0.000281	0.00451	CcSEcCtD
Candesartan—Nausea—Furosemide—dilated cardiomyopathy	0.00028	0.0045	CcSEcCtD
Candesartan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000279	0.00449	CcSEcCtD
Candesartan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000279	0.00449	CcSEcCtD
Candesartan—ABCB1—heart—dilated cardiomyopathy	0.00027	0.0165	CbGeAlD
Candesartan—Asthenia—Lisinopril—dilated cardiomyopathy	0.000253	0.00407	CcSEcCtD
Candesartan—Pruritus—Lisinopril—dilated cardiomyopathy	0.00025	0.00402	CcSEcCtD
Candesartan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000242	0.00389	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000241	0.0121	CbGpPWpGaD
Candesartan—Dizziness—Lisinopril—dilated cardiomyopathy	0.000234	0.00376	CcSEcCtD
Candesartan—Vomiting—Lisinopril—dilated cardiomyopathy	0.000225	0.00361	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000224	0.0112	CbGpPWpGaD
Candesartan—Rash—Lisinopril—dilated cardiomyopathy	0.000223	0.00358	CcSEcCtD
Candesartan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000223	0.00358	CcSEcCtD
Candesartan—Headache—Lisinopril—dilated cardiomyopathy	0.000221	0.00356	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000216	0.0108	CbGpPWpGaD
Candesartan—Nausea—Lisinopril—dilated cardiomyopathy	0.00021	0.00337	CcSEcCtD
Candesartan—Losartan—ACE—dilated cardiomyopathy	0.000186	0.0208	CrCbGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000185	0.0093	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000185	0.0093	CbGpPWpGaD
Candesartan—AGTR1—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000184	0.00927	CbGpPWpGaD
Candesartan—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000173	0.00871	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000172	0.00865	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000149	0.00751	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000145	0.00728	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000137	0.0069	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000135	0.00677	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.000132	0.00664	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000131	0.00657	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00013	0.00656	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000124	0.00624	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000124	0.00624	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000116	0.00581	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000115	0.0058	CbGpPWpGaD
Candesartan—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000112	0.00562	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000112	0.00562	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00011	0.00554	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000107	0.00539	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000106	0.00531	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000101	0.0051	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000101	0.00507	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.0001	0.00503	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.0001	0.00503	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.46e-05	0.00475	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.46e-05	0.00475	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—TNF—dilated cardiomyopathy	9.16e-05	0.0046	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	9.11e-05	0.00458	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	9.07e-05	0.00456	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	9.06e-05	0.00455	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.79e-05	0.00442	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.51e-05	0.00428	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ANKRD1—dilated cardiomyopathy	8.48e-05	0.00426	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	8.43e-05	0.00424	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TAZ—dilated cardiomyopathy	7.97e-05	0.00401	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SDHA—dilated cardiomyopathy	7.21e-05	0.00362	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	7.06e-05	0.00355	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.93e-05	0.00348	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.9e-05	0.00347	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.72e-05	0.00338	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	6.57e-05	0.0033	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.51e-05	0.00327	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	6.33e-05	0.00318	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	6.3e-05	0.00316	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.64e-05	0.00283	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.34e-05	0.00268	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.34e-05	0.00268	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.3e-05	0.00266	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	5.12e-05	0.00257	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.97e-05	0.0025	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.85e-05	0.00244	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.85e-05	0.00244	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.81e-05	0.00242	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	4.78e-05	0.0024	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.51e-05	0.00227	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	4.49e-05	0.00226	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.38e-05	0.0022	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.37e-05	0.00219	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	4.32e-05	0.00217	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.09e-05	0.00205	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	4.06e-05	0.00204	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.98e-05	0.002	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.98e-05	0.002	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.9e-05	0.00196	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.7e-05	0.00186	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.54e-05	0.00178	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.24e-05	0.00163	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.23e-05	0.00162	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.13e-05	0.00157	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	3.09e-05	0.00155	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.06e-05	0.00154	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.03e-05	0.00152	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	2.9e-05	0.00146	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.89e-05	0.00145	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.87e-05	0.00144	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.87e-05	0.00144	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.75e-05	0.00138	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	2.69e-05	0.00135	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	2.69e-05	0.00135	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.66e-05	0.00134	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.63e-05	0.00132	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	2.62e-05	0.00132	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.58e-05	0.0013	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.53e-05	0.00127	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.51e-05	0.00126	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.48e-05	0.00124	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.41e-05	0.00121	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.36e-05	0.00119	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.29e-05	0.00115	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.17e-05	0.00109	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.14e-05	0.00107	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.09e-05	0.00105	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.03e-05	0.00102	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GPX1—dilated cardiomyopathy	1.96e-05	0.000984	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CD36—dilated cardiomyopathy	1.91e-05	0.000958	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.82e-05	0.000915	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.8e-05	0.000903	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AGT—dilated cardiomyopathy	1.72e-05	0.000863	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.62e-05	0.000816	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.6e-05	0.000804	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.56e-05	0.000783	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AGT—dilated cardiomyopathy	1.55e-05	0.000779	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.4e-05	0.000705	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.39e-05	0.0007	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.33e-05	0.000667	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.3e-05	0.000654	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.27e-05	0.000637	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.25e-05	0.000628	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.14e-05	0.000574	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	1.1e-05	0.000554	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.08e-05	0.000541	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD36—dilated cardiomyopathy	1.07e-05	0.00054	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGT—dilated cardiomyopathy	9.67e-06	0.000486	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.07e-06	0.000405	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.38e-06	0.000371	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	7.13e-06	0.000358	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	6.94e-06	0.000349	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	6.25e-06	0.000314	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	6.21e-06	0.000312	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD36—dilated cardiomyopathy	6.05e-06	0.000304	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	5.8e-06	0.000291	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.65e-06	0.000284	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGT—dilated cardiomyopathy	5.44e-06	0.000273	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.09e-06	0.000256	CbGpPWpGaD
